Drug Development Research Journal Citation Rate 2026
0272-4391
eISSN 1098-2299
Wiley
US
Q2 Quartile Established Impact Verified Publisher
About Drug Development Research
Drug Development Research (DDR) is a peer-reviewed academic journal covering Adenosine and Purinergic Signaling and Cholinesterase and Neurodegenerative Diseases, published by Wiley in US, catalogued under ISSN 0272-4391 (e-ISSN 1098-2299). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.95 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3610 USD).
Drug Development Research Citation Rate 2026 — In Context
Drug Development Research has a 2025 2-Year Citation Rate (OpenAlex) of 2.95, placing it in the Q2 quartile within the Adenosine and Purinergic Signaling research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Drug Development Research operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Drug Development Research should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Drug Development Research against similar journals in the field, use our journal comparison tool.
Submission Tips for Drug Development Research
- Budget $3610 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Adenosine and Purinergic Signaling, Cholinesterase and Neurodegenerative Diseases, Neuroscience and Neuropharmacology Research. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Drug Development Research Compares
Compared against 12 journals in the same research areas.
| ISSN (Print) | 0272-4391 |
|---|---|
| ISSN (Online) | 1098-2299 |
| Publisher | Wiley |
| Country | United States |
| APC / Cost | $3610 USD |
In-depth profile & metrics
Drug Development Research is published by Wiley and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 3610.
In our subject taxonomy, Drug Development Research is classified under Adenosine and Purinergic Signaling, Cholinesterase and Neurodegenerative Diseases, Neuroscience and Neuropharmacology Research and Neurotransmitter Receptor Influence on Behavior.
Drug Development Research is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 2.953.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Drug Development Research
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 2.953 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Drug Development Research against similar publications in its field:
Related Journals in Your Field
-
Pharmacology & Therapeutics Elsevier BV IF 10.38
-
Acta Pharmacologica Sinica Springer Nature IF 6.71
-
Current Opinion in Neurobiology Elsevier BV IF 4.32
-
BMC Neuroscience BioMed Central IF 3.54
-
Frontiers in Behavioral Neuroscience Frontiers Media IF 2.98
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S26306840
Get weekly updates for Adenosine and Purinergic Signaling journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.